DUBLIN, July 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the company will present 29 abstracts at the 61st American Headache Society (AHS) Meeting, including one late-breaking podium presentation, five oral podium presentations and 23 poster presentations. The presentations will continue to highlight Allergan's ongoing innovation in t

Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of Alzheimer's disease TORONTO and CAMBRIDGE, MA, July 9, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focus

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate venture capital partner and wholly owned indirect subsidiary of Cigna Corporation (NYSE: CI). Joining the Cigna

LOS ANGELES, July 9, 2019 /PRNewswire/ -- Zynx Health™, market leader in providing evidence- and experience-based clinical improvement solutions since 1996, announced today that long-time client A

REDWOOD CITY, Calif., July 9, 2019 /PRNewswire/ -- REVOLUTION Medicines, Inc., a clinical-stage leader in the discovery and development of novel small molecule inhibitors of frontier oncology targets within notorious pathways, today announced the closing of a $100 million Series C equity financing.  Proceeds will support continued

TORONTO and HOUSTON, July 9, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received US$1,915,264 (approximately, CD$2.5M) from the Cancer Prevention and Research Institute of

NEW ORLEANS, July 9, 2019 /PRNewswire/ -- AxoSim, Inc., the premier provider of neuroscience discovery platforms that mimic the structure and function of the human nervous system, today announced publication of a new 

Now Available at Major U.S. Retailers BRIDGEWATER, N.J., July 9, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S. launch of Ocuvite® Eye Performance vitamins, a nutritional supplement designed to meet the changing need

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington's disease, a rare, genetically inherited disease that causes the ne

SAN RAMON, Calif., July 9, 2019 /PRNewswire/ -- Board-Certified urologist and specialist in male sexual medicine, Dr. Judson Brandeis, is launching the world's lar